Retail Partnerships

Showing 1677 articles
Business

XRP's 40% Plunge: A Buying Opportunity or a Value Trap?

XRP, the cryptocurrency designed for global payments, has seen its value tumble over 40% in the past year. While its long-term promise to reshape cross-border finance remains, investors now face a critical juncture: is this a chance to buy the dip, or a sign of deeper troubles ahead?

Business

AbCellera Biologics: A Valuation Crossroads After Volatile Returns

Shares of antibody discovery firm AbCellera Biologics (ABCL) present a complex picture for investors, with strong one-year gains overshadowed by steep declines over longer horizons. As the stock trades near $3.86, a significant gap emerges between its market price and some analyst fair value estimates, raising questions about its premium valuation in a challenging biotech market.